ASX
Imugene Limited
IMU:ASX•Healthcare
Sensitive ASX Announcement
IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL
Published: 18/05/22, 08:22am (AEST)•5 pages